Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Altamira Therapeutics Ltd. - Common Shares
(NQ:
CYTO
)
0.3001
UNCHANGED
Last Price
Updated: 3:55 PM EST, Dec 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.3001
Bid (Size)
0.2800 (2)
Ask (Size)
0.2870 (58)
Prev. Close
0.3001
Today's Range
0.3001 - 0.3001
52wk Range
N/A - N/A
Shares Outstanding
12,869,587
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Via
Performance
Frequently Asked Questions
Is Altamira Therapeutics Ltd. - Common Shares publicly traded?
Yes, Altamira Therapeutics Ltd. - Common Shares is publicly traded.
What exchange does Altamira Therapeutics Ltd. - Common Shares trade on?
Altamira Therapeutics Ltd. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Altamira Therapeutics Ltd. - Common Shares?
The ticker symbol for Altamira Therapeutics Ltd. - Common Shares is CYTO on the Nasdaq Stock Market
What is the current price of Altamira Therapeutics Ltd. - Common Shares?
The current price of Altamira Therapeutics Ltd. - Common Shares is 0.3001
When was Altamira Therapeutics Ltd. - Common Shares last traded?
The last trade of Altamira Therapeutics Ltd. - Common Shares was at 12/19/24 03:55 PM ET
What is the market capitalization of Altamira Therapeutics Ltd. - Common Shares?
The market capitalization of Altamira Therapeutics Ltd. - Common Shares is 3.86M
How many shares of Altamira Therapeutics Ltd. - Common Shares are outstanding?
Altamira Therapeutics Ltd. - Common Shares has 4M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.